Brian Feth and Jonathan Grinstein go behind the headlines to discuss the impact of a Republican administration on Federal ...

Pharmaceutical Technology® caught up with Brittany Hayes, PhD, Highly Potent & Oncology Platform Director at CordenPharma, ...

A £520 million investment for manufacturing capacity was announced by Chancellor of the Exchequer, Rachel Reeves, but ...

Balversa (erdafitinib) marks the first and only bladder cancer therapy to target FGFR3 alterations, with a demonstrated ...

High-throughput screening (HTS) enables the rapid testing of numerous compounds against biological targets. By automating and ...

Evolving industry demands are driving the need for greater flexibility and innovation in processing equipment for ...

Shifting to automated, closed modular manufacturing systems is growing increasingly crucial for biopharmaceutical production.

Ascend’s fill/finish capacity in the US will also be expanded. “We founded Ascend with a vision to quilt together the best operators and technologies within the advanced manufacturing field. The ...